US Map / Texas
State TX

Clinical Trials in Texas

Recruiting clinical trials with at least one study location in Texas. Data updated daily from ClinicalTrials.gov.

Total Trials
365
Recruiting Now
365
← Back to US Map
Top Conditions in Texas
Breast Cancer (9)Advanced Solid Tumor (7)Prostate Cancer (6)Pancreatic Cancer (5)Multiple Myeloma (5)Acute Myeloid Leukemia (5)Advanced Solid Tumors (5)Asthma (5)Endometrial Cancer (5)Non-small Cell Lung Cancer (4)Systemic Lupus Erythematosus (4)Ovarian Cancer (4)

Frequently Asked Questions — Clinical Trials in Texas

How many clinical trials are currently recruiting in Texas?
ClinicalMetric currently tracks 365 actively recruiting clinical trials with at least one location in Texas. The total number of registered studies—including active but not currently enrolling trials—is 365. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Texas?
Texas hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Advanced Solid Tumor, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Texas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Texas?
To join a clinical trial in Texas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Texas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Texas

NCT06174103 N/A
Recruiting
BiVACOR® Total Artificial Heart Early Feasibility Study
Condition
Heart Failure
Enrollment
5 pts
Location
United States
Sponsor
BiVACOR Inc.
View Trial →
NCT04879329 Phase 2
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer Th...
Condition
Urothelial Carcinoma
Enrollment
372 pts
Location
United States, Argentina, Australia
Sponsor
Seagen, a wholly owned subsidi
View Trial →
NCT06896903 N/A
Recruiting
Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate T...
Condition
ANOCA - Angina With Non-obstructive Coronary Arteries
Enrollment
50 pts
Location
United States
Sponsor
Baylor Research Institute
View Trial →
NCT06976203 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Imp...
Condition
Alzheimer's Disease
Enrollment
586 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT05906953 Phase 1, Phase 2
Recruiting
Safety and Efficacy Trial of HG004 for Leber Congenital Amaurosis Related to Rpe...
Condition
Leber Congenital Amaurosis
Enrollment
20 pts
Location
United States, China
Sponsor
HuidaGene Therapeutics Co., Lt
View Trial →
NCT07444268 Phase 1
Recruiting
How [14C]-DSP-5336 is Absorbed, Broken Down, and Removed From the Body After a S...
Condition
Advanced Hematologic Malignancies
Enrollment
8 pts
Location
United States
Sponsor
Sumitomo Pharma America, Inc.
View Trial →
NCT07486362 N/A
Recruiting
Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Follo...
Condition
Bacteremia
Enrollment
126 pts
Location
United States
Sponsor
Methodist Health System
View Trial →
NCT07052942 Phase 4
Recruiting
Individualizing Treatment for Asthma in Primary Care (Full Study)
Condition
Asthma
Enrollment
3,200 pts
Location
United States
Sponsor
DARTNet Institute
View Trial →
NCT06395103 Phase 1, Phase 2
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants Wit...
Condition
B-cell Acute Lymphoblastic Leukemia
Enrollment
90 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06727305 Phase 1, Phase 2
Recruiting
MTOR Inhibitors in Older Adults
Condition
Aging
Enrollment
60 pts
Location
United States
Sponsor
University of Texas Southweste
View Trial →
NCT06995677 Phase 2
Recruiting
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, In...
Condition
Low-grade NMIBC
Enrollment
90 pts
Location
United States, Australia, Italy
Sponsor
Tyra Biosciences, Inc
View Trial →
NCT06532942 Phase 1
Recruiting
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MKND-201 in Hea...
Condition
Healthy Volunteers
Enrollment
40 pts
Location
United States
Sponsor
Mannkind Corporation
View Trial →
NCT04239573 N/A
Recruiting
Comparing Two Methods to Follow Patients With Pancreatic Cysts
Condition
Pancreatic Carcinoma
Enrollment
4,606 pts
Location
United States, Canada, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT06480383 Phase 2
Recruiting
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiet...
Condition
Generalized Anxiety Disorder
Enrollment
705 pts
Location
United States, Bulgaria, Czechia
Sponsor
Intra-Cellular Therapies, Inc.
View Trial →
NCT03999983 N/A
Recruiting
Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)
Condition
Vertebral Artery Stenosis
Enrollment
150 pts
Location
United States
Sponsor
St. Louis University
View Trial →
NCT07455383 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolep...
Condition
Narcolepsy Type 1
Enrollment
150 pts
Location
United States
Sponsor
Alkermes, Inc.
View Trial →
NCT07425522 Phase 1
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokine...
Condition
Diabetic Macular Edema
Enrollment
93 pts
Location
United States
Sponsor
Genentech, Inc.
View Trial →
NCT06957756 Phase 1
Recruiting
A Study to Test How BI 1584862 is Taken up in the Blood of People With and Witho...
Condition
Hepatic Insufficiency
Enrollment
44 pts
Location
United States
Sponsor
Boehringer Ingelheim
View Trial →
NCT06100172 N/A
Recruiting
Transcutaneous Auricular Neurostimulation After Lumbar Surgery
Condition
Pain, Postoperative
Enrollment
20 pts
Location
United States
Sponsor
University of Texas Southweste
View Trial →
NCT07219680 N/A
Recruiting
Intervention for Communication Quality of Life in Primary Progressive Aphasia
Condition
Primary Progressive Aphasia(PPA)
Enrollment
30 pts
Location
United States
Sponsor
Maya Henry
View Trial →
NCT05064280 Phase 2
Recruiting
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With ...
Condition
Brain Metastases
Enrollment
104 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT05264779 N/A
Recruiting
The Periviable GOALS Decision Support Tool
Condition
Pregnancy Preterm
Enrollment
300 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT07546760 Phase 1
Recruiting
A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and A...
Condition
Hepatic Impairment
Enrollment
28 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT05408559 Phase 1, Phase 2
Recruiting
Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES
Condition
Diastolic Dysfunction
Enrollment
200 pts
Location
United States
Sponsor
Texas Tech University Health S
View Trial →
Page 5 of 15 — 365 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology